Publications
Search
Oncology
05/18/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Ryan Moy, MD, PhD, discussed first-line use of anti PD-1 inhibitors for the treatment of patients with gastroesophageal cancers.
Oncology
05/18/2024
At Great Debates and Updates in Gastrointestinal Malignancies in New York, New York, Samuel Cytryn, MD, discussed first-line use of claudin-18.2 inhibitors for patients with gastroesophageal cancers.
Psych Congress Network
05/17/2024
A literature review presented via poster at the 2024 American Psychiatric Association Annual Meeting in New York City suggests that video games may not be all-harm in effect for youth with ADHD.
Podiatry Today, Wound Care
05/17/2024
Dr. Vlahovic shares key points from her Rapid Fire session at SAWC.
Psych Congress Network
05/17/2024
Lenard A.
Pharmacy Learning Network
05/17/2024
“Prescription medications, when misused, can pose a grave threat to public health,” said Acting Special Agent in Charge Steven L. Hofer of the DEA. “That’s why meticulous recordkeeping by pharmacies is an essential line of defense against the opioid crisis. Every dose, every pill meticulously accounted for protects communities and saves lives.”
EMSWorld
05/17/2024
Limosa Inc., an innovative eVTOL manufacturer, developed an electric air taxi LimoConnect V2, and recently announced the air ambulance version of this eVTOL — the LimoMedic.
Oncology
05/17/2024
Results from the ORANGE II PLUS trial demonstrated that a minimally invasive, laparoscopic approach to hemihepatectomy shortened time to functional recovery compared to open, major hemihepatectomy among patients with primary or metastatic liver tumors.
Oncology
05/17/2024
Based on results from the DELLphi-301 trial, the FDA has granted accelerated approval to tarlatamab for patients with extensive-stage small cell lung cancer.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/17/2024
Professor Serruys, Chairman & study director of the LANDMARK trial, said, "Myval THV series are novel next-gen THV devices; non-inferior to the Sapien and Evolut THV series. Myval THV series have a unique size matrix incorporating conventional, intermediate and extra-large diameters with increasing diameter steps of 1.5mm that match and fit precisely the multi slice CT scan-defined aortic annulus area of each individual patient, as a result, provides a superior effective orifice area on echocardiography, which may impact on durability and long-term clinical outcomes."
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/17/2024
SignalHF is unique in that the manufacturer-agnostic solution can be used to analyze data collected from a variety of CIEDs, including implantable cardiac defibrillators (ICD), pacemakers (PM) and cardiac resynchronization therapy devices (CRT-P, CRT-D) from Biotronik, Boston Scientific and Medtronic.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/16/2024
DESyne BDS Plus has a bioresorbable coating containing three drugs: two anticoagulants (rivaroxaban and argatroban) and an antiproliferative mTOR inhibitor (sirolimus) designed for delivery of site-specific antithrombotic therapeutic.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/16/2024
The novel LithiX Hertz Contact Intravascular Lithotripsy (IVL) system is designed to address challenges associated with the percutaneous treatment of nodular, concentric, and eccentric moderate to severe calcified lesions resistant to optimal stent expansion.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/16/2024
Elixir Medical announced two-year results from the BIOADAPTOR randomized controlled (1:1) trial, comparing the DynamX® Coronary Bioadaptor System to standard of care Resolute Onyx™ Drug-Eluting Stent from 34 centers in Japan, Europe, and New Zealand.
Journal of Clinical Pathways
05/16/2024
Lalan Wilfong, MD, discusses his key takeaways from the Community Oncology Conference session on defining value-based care in oncology.
EMSWorld
05/16/2024
Deaths from drug overdoses fell last year in the United States as fewer people lost their lives to fentanyl and other opioids, marking the first time the death toll had dropped in five years, according to the CDC.
Today's Wound Clinic, Wound Care
05/16/2024
Given the increased number of audits of those frequently using CTPs, and the recent release of proposed LCDs and LCAs on using CTPs for DFUs and VLUs, this SAWC Spring speaker discusses 10 major facts about CTP reimbursement.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/16/2024
The newly granted patent bolsters the innovative design of FastWave's next-generation IVL platform, aimed at overcoming challenges associated with treating calcified arteries in patients with occlusive vascular disease.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/16/2024
“REACT will develop – at scale - methods to directly visualize the disease (atherosclerosis),” says Dr. Borja Ibáñez, Scientific Director of CNIC, cardiologist at Fundación Jiménez Díaz hospital, and leader of the Spanish part of the study.
The Dermatologist
05/16/2024
In our next segment of the ElderDerm Podcast, listen to co-hosts Dr Adam Friedman and Jaya Manjunath discuss what shared decision making is, and why it is important in dermatology.